Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 11, 2007

View Archived Issues

Further data presented on rotigotine patch efficacy in restless legs syndrome

Silencing mTOR useful in experimental proliferative vitreoretinopathy

Novel antidiabetic agents disclosed in recent patent literature

Discovery, preclinical and clinical activity of INCB-018424 described

Zanolimumab activity in peripheral T-cell lymphoma demonstrated in open study

AVE-5026 dose-dependently prevents venous thromboembolism in TREK study

EntreMed initiates phase II study with MKC-1 in pancreatic cancer

Vion initiates Cloretazine trials in combination with stem cell transplantation

Cipher enters formal dispute resolution process to appeal FDA decision on CIP-Tramadol ER

Biotest AG acquires Nabi's biologics strategic business unit for USD 185 million

Metastatix initiates phase I clinical trial of MSX-122 for late-stage solid tumors

Theregen completes enrollment in phase I safety trial of Anginera

Theravance reports positive results from ATTAIN 1 and 2 clinical studies of telavancin

Epiphany initiates phase II trial of valomaciclovir for acute infectious mononucleosis

FDA advisory committee recommends approval of tetrabenazine for chorea linked with HD

Nventa completes enrollment and initiates dosing of second cohort in phase I trial of HspE7

Amarin signs agreement to acquire Ester Neurosciences

SIGA reports positive preliminary results from human clinical trial of ST-246

Pfizer and Adolor enter collaborative agreement for ADL-5859 and ADL-5747

Primary endpoint of phase III clinical trial achieved by Durect's Remoxy

Catalyst reports positive phase II trial results for vigabatrin for cocaine addiction

mAbs against SOD1 exhibit therapeutic potential for ALS in preclinical studies

Novel oncolytic drugs covered in recent patents

Amylin and Lilly report positive results from study of Byetta for type 2 diabetes

Bristol-Myers Squibb reports results for the third quarter 2007

Nycomed files MAA with the EMEA for an intranasal fentanyl spray

Janssen-Cilag submits MAA to the EMEA for dapoxetine for premature ejaculation

Taro patents novel antimicrobial compound isolated from Streptomyces

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 16, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...